Guidance for FDA staff and industry : marketed unapproved drugs, compliance policy guide.
| Format | Electronic |
| Publication Info | Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2006] |
| Description | 1 online resource (i, 12 pages) |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS116482 |
| Subjects |
| Portion of title | Marketed unapproved drugs, compliance policy guide |
| General note | "Sec. 440.100 marketed new drugs without approved NDAs or ANDAs." |
| General note | "Compliance." |
| General note | "June 2006." |
| GPO item number | 0499-P (online) |
| Govt. docs number | HE 20.4708:M 34 |
Availability
| Library | Location | Call Number | Status | Item Actions |
|---|---|---|---|---|
| Electronic Resources | Access Content Online | ✔ Available |